Agathos is a healthcare technology company focused on organizing health data and generating insights to improve patient outcomes. Their key products, Agathos Care Reflect and Agathos Care Resilience, engage physicians by providing real-time feedback on practice patterns and ensuring data availability during EHR downtimes. This differentiation allows hospitals to lower care costs while enhancing quality and safety. With a strong emphasis on physician engagement, Agathos aims to make valuable care obvious and normal, positioning itself as a leader in the healthcare analytics space.

Allergy Amulet is a pioneering company that has developed the world’s smallest and fastest food allergen sensor, designed to detect allergenic ingredients in food within approximately one minute. The Amulet is a portable device that allows users to test their food for the presence of the top 9 allergens, including peanuts, tree nuts, and gluten, thereby enhancing food safety and reducing anxiety for individuals with food allergies. The company is driven by a personal connection to the food allergy community, as its founders include individuals who have experienced the challenges of living with food allergies. With a strong emphasis on innovation and user experience, Allergy Amulet aims to improve the quality of life for millions affected by food allergies globally, positioning itself as a leader in the food safety technology market.

AMOpportunities is a leading provider of clinical training solutions, connecting international medical students and graduates with U.S. healthcare institutions for clinical experiences. With over a decade of experience, AMO has established a robust network of more than 100 institutions that trust it for clinical placement management. The company offers tailored solutions that meet the needs of schools and students, ensuring compliance with accreditation standards. AMO's platform supports over 500 clinical experiences across various specialties, providing exceptional support services such as visa assistance and flexible scheduling. The company has secured over 50 new partnerships with U.S. educational institutions in 2023 alone, solidifying its position as a key player in the healthcare education sector.

Arcascope is a technology company focused on circadian rhythms, offering products like Arcashift, which is designed for shift workers to improve their sleep quality. The company leverages scientific research and expertise from a team with over 30 years of experience in the sleep and circadian space. Their products provide personalized recommendations based on real-time data, differentiating them in the market. Arcascope has gained traction through partnerships, including one with Henry Ford Health, and has been recognized in various startup lists, indicating a strong market position.

Bento is on a mission to eliminate food insecurity by connecting members with nutritious, dietitian-curated groceries delivered from local grocery stores via SMS. The company combines technology with compassionate caseworkers to address the nutritional needs of vulnerable populations, ensuring a stigma-free experience. With a focus on health equity, Bento aims to improve health outcomes for millions of Americans facing food insecurity, leveraging partnerships with healthcare and community organizations to deliver tailored grocery orders that meet individual dietary needs. Their innovative approach has garnered recognition, including being part of the Fortune Impact 20 and TIME's Best Inventions.

Cancer IQ is a digital healthcare technology platform that enables healthcare providers to implement personalized cancer prevention and early detection strategies. Their comprehensive solution standardizes risk assessment, automates documentation, and tracks medical management changes, allowing providers to focus on patient care. With a robust content library of evidence-based guidelines and risk models, Cancer IQ empowers providers to engage patients effectively and navigate them to appropriate genetic testing and treatment interventions. The platform is currently implemented in over 200 clinical locations across the country, demonstrating significant traction in the healthcare market.

Cardamom Health is an EHR consulting services firm that specializes in data, analytics, and application support for healthcare organizations. The company leverages a team-based approach to address complex IT and operational challenges, focusing on patient engagement, value-based care, and revenue cycle optimization. By providing flexible, results-based solutions, Cardamom Health aims to improve quality, financial performance, and patient outcomes while reducing IT costs. Their unique value proposition lies in their commitment to enhancing the healthcare experience through actionable insights derived from robust data integration and advanced analytics, positioning them as a leader in the healthcare IT services market.

CareX.AI delivers an AI-powered, video-based software as a medical device platform that transforms any camera-equipped device into a regulatory vital signs monitoring solution.

Doc Station is an all-in-one revenue-generating software platform designed specifically for pharmacies. It empowers pharmacies to bill for services, manage patient care, and participate in payer-sponsored programs through a comprehensive electronic health record (EHR) system. By connecting pharmacies with payers, Doc Station enhances clinical operations, improves patient outcomes, and reduces costs. The platform supports pharmacies of all sizes, from those just starting to those submitting thousands of claims monthly, making it a vital tool in the evolving pharmacy business model.

Dyania Health is a deep tech company specializing in AI-driven solutions for healthcare, particularly through its proprietary Synapsis AI platform. This platform automates the manual review of electronic medical records (EMRs), enabling healthcare professionals to access critical patient information in just 0.5 seconds, compared to the traditional 30 minutes required by human clinicians. Dyania's unique approach combines the expertise of full-time physicians with advanced AI research, achieving over 95% accuracy in medical data processing. The company aims to enhance patient care by ensuring timely access to relevant medical histories and clinical trial opportunities, positioning itself as a leader in the healthcare AI market with significant traction among healthcare systems and pharmaceutical sponsors.

EnsoData is a pioneering company that leverages artificial intelligence to enhance the efficiency and accuracy of sleep medicine. Their flagship product, Enso Sleep, is a cloud-based software platform that automates the scoring of sleep studies, significantly reducing the time clinicians spend on data processing. With a robust database of over 1,750,000 studies, Enso Sleep integrates seamlessly into clinical workflows, allowing healthcare providers to focus more on patient care. The platform has demonstrated real-world impact, scoring over 800,000 patient studies and supporting more than 75,000 patients monthly. EnsoData's innovative approach positions it as a leader in the sleep health technology market, addressing the growing demand for efficient sleep disorder management.

Geno.Me is a data exchange platform that empowers underrepresented individuals to share their health and genetic data with researchers. By linking health systems and genetic information, the platform facilitates access to clinical research opportunities, including clinical trials and pharmaceutical R&D, while ensuring a secure and HIPAA-compliant process. Users are compensated for their contributions, positioning Geno.Me as a leader in advancing medical research and improving healthcare transparency. Founded in 2020 and headquartered in Milwaukee, Wisconsin, the company is dedicated to changing the world for the better through innovative healthcare solutions.